GlassScriptPhysician profile
Lori J Izabal
NPI 1114992328
$4,270.52
in general payments reported to CMS, 2019-2025
42 companies · $533 in 2025
The $533 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $675 · 2021: $721 · 2022: $512 · 2023: $854 · 2024: $622 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,008.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,028.33 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $324.04 | 2019-2021 | |
| Lilly USA, LLC | $314.85 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $269.69 | 2019-2024 | |
| Allergan, INC. | $257.62 | 2019-2020 | |
| Novo Nordisk INC | $185.45 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $153.43 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $142.05 | 2024-2025 | Airsupra |
| Merck Sharp & Dohme LLC | $118.72 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $103.34 | 2022 | |
| Exact Sciences Corporation | $96.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Adlon Therapeutics L.P. | $89.91 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $88.70 | 2020-2021 | |
| Eisai INC. | $85.91 | 2020-2021 | |
| Axsome Therapeutics, INC. | $78.41 | 2023 | Auvelity |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Izabal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.